Comparing two methods to find early signs of cancer in inflammatory bowel disease
Part of Digestive system clinical trials.
This study compares two ways of looking at the colon during a routine check-up to find early signs of cancer in people with inflammatory bowel disease (IBD). One method uses a special light, and the other uses a dye. The goal is to see which is better at finding these signs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 16 years old.
- You have inflammatory bowel disease (Crohn's disease or ulcerative colitis).
- You are having a routine colonoscopy to check for signs of cancer.
- Your disease has affected your colon for at least 8 years, or you also have primary sclerosing cholangitis (PSC).
- You are not taking blood thinners that cannot be paused before the procedure.
- You are not allergic to the dye used in one of the methods (indigo carmine).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new camera system that adds texture and color enhancement to the usual white light during a colonoscopy. It aims to see if this new view helps doctors spot signs of inflammation or early cancer more clearly in people with inflammatory bowel disease.
This study looks at immune system changes in people around the time inflammatory bowel disease (IBD) is first diagnosed, and compares different groups (new, very recent, or not found on scope). It may help researchers understand what the immune system looks like early in IBD and later in people who don’t show it on colonoscopy.
This study compares two ways to examine your colon during a surveillance colonoscopy for IBD: a virtual method using standard light and a dye-based method that sprays a blue dye to highlight abnormal areas. The goal is to see which method is better at finding precancerous changes to help prevent colon cancer.
This study looks at people with Crohn's disease or ulcerative colitis who are having a colonoscopy to check for abnormal cells in the colon. The goal is to learn more about these growths and how likely they are to become cancer over time, which could help improve future monitoring and treatment.
This trial tests a new imaging technique that may help doctors see inflammation more clearly during colonoscopy in people with Crohn's disease or ulcerative colitis. The technique is called Texture and Color Enhancement Imaging (TXI).
This study compares different special camera techniques during colonoscopy to see which best finds early abnormal (pre-cancer) changes in people with long-term ulcerative colitis. It may help doctors improve how they screen and monitor your colon over time.
Hear when a new IBD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.